Sept 7 (Reuters) - Pharmaxis Ltd PXS.AX :
* CO & BOEHRINGER INGELHEIM ANNOUNCE DISCONTINUATION OF DEVELOPMENT OF ANTI-INFLAMMATORY AOC3 INHIBITOR FOR DIABETIC RETINOPATHY
Sept 7 (Reuters) - Pharmaxis Ltd PXS.AX :
* CO & BOEHRINGER INGELHEIM ANNOUNCE DISCONTINUATION OF DEVELOPMENT OF ANTI-INFLAMMATORY AOC3 INHIBITOR FOR DIABETIC RETINOPATHY